Ghent University Academic Bibliography

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

Julie Heremans, Robin Maximilian Awad, Jessica Bridoux, Thomas Ertveldt, Vicky Caveliers, Annemieke Madder (UGent) , Richard Hoogenboom (UGent) , Nick Devoogdt, Steven Ballet, Sophie Hernot, et al.

(2024) EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 196.

Add to list

Journal Article
A1
open access

Decoding immunogenic cell death from a dendritic cell perspective

Sophie Janssens (UGent) , Sofie Rennen (UGent) and Patrizia Agostinis

(2024) IMMUNOLOGICAL REVIEWS. 321(1). p.350-370

Add to list

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

Valérie Desmedt, Aranzazu Jauregui-Amezaga, Liselotte Fierens, Sandrine Aspeslagh, Jeroen Dekervel, Els Wauters, Marc Peeters, Joao Sabino, Lara Crape, Michael Somers, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 187. p.36-57

Add to list

Journal Article
A1
open access

Delivery of STING agonists for adjuvanting subunit vaccines

Simon Van Herck (UGent) , Bing Feng and Li Tang

(2021) ADVANCED DRUG DELIVERY REVIEWS. 179.

Add to list

Synthetic rhamnose glycopolymer cell-surface receptor for endogenous antibody recruitment

Ruben De Coen (UGent) , Lutz Nuhn, Chamani Perera, Maria Arista-Romero, Martijn Risseeuw (UGent) , Alec Freyn, Raffael Nachbagauer, Lorenzo Albertazzi, Serge Van Calenbergh (UGent) , David A. Spiegel, et al.

(2020) BIOMACROMOLECULES. 21(2). p.793-802

Add to list

Molecular and cellularf unctions of CTLA-4

Samya Van Coillie, Bartosz Wiernicki and Jie Xu

(2020) REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY. 1248. p.7-32

Add to list

Journal Article
A1
open access

Three decades of messenger RNA vaccine development

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2019) NANO TODAY. 28.

Add to list

Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte (UGent) , et al.

(2018) ACS NANO. 12(10). p.9815-9829

Add to list

Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist

Lutz Nuhn (UGent) , Lien Van Hoecke (UGent) , Kim Deswarte (UGent) , Bert Schepens (UGent) , Yupeng Li, Bart Lambrecht (UGent) , Stefaan De Koker (UGent) , Sunil A David, Xavier Saelens (UGent) and Bruno De Geest (UGent)

(2018) BIOMATERIALS. 178. p.643-651

Add to list

Nanoparticle-conjugate TLR7/8 agonist localized immunotherapy provokes safe antitumoral responses

Lutz Nuhn (UGent) , Stefaan De Koker (UGent) , Sandra Van Lint (UGent) , Zifu Zhong (UGent) , João Portela Catani (UGent) , Francis Combes (UGent) , Kim Deswarte (UGent) , Yupeng Li, Bart Lambrecht (UGent) , Stefan Lienenklaus, et al.

(2018) ADVANCED MATERIALS. 30(45).

Academic Bibliography

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

Decoding immunogenic cell death from a dendritic cell perspective

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

Delivery of STING agonists for adjuvanting subunit vaccines

Synthetic rhamnose glycopolymer cell-surface receptor for endogenous antibody recruitment

Molecular and cellularf unctions of CTLA-4

Three decades of messenger RNA vaccine development

Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist

Nanoparticle-conjugate TLR7/8 agonist localized immunotherapy provokes safe antitumoral responses

Contents

Support

Contact